169 related articles for article (PubMed ID: 35970996)
1. Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.
Masud SN; Chandrashekhar M; Aregger M; Tan G; Zhang X; Mero P; Pirman DA; Zaslaver O; Smolen GA; Lin ZY; Wong CJ; Boone C; Gingras AC; Montenegro-Burke JR; Moffat J
Nat Chem Biol; 2022 Dec; 18(12):1370-1379. PubMed ID: 35970996
[TBL] [Abstract][Full Text] [Related]
2. The novel role of pyrvinium in cancer therapy.
Momtazi-Borojeni AA; Abdollahi E; Ghasemi F; Caraglia M; Sahebkar A
J Cell Physiol; 2018 Apr; 233(4):2871-2881. PubMed ID: 28500633
[TBL] [Abstract][Full Text] [Related]
3. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
4. Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.
Li B; Flaveny CA; Giambelli C; Fei DL; Han L; Hang BI; Bai F; Pei XH; Nose V; Burlingame O; Capobianco AJ; Orton D; Lee E; Robbins DJ
PLoS One; 2014; 9(7):e101969. PubMed ID: 25003333
[TBL] [Abstract][Full Text] [Related]
5. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
6. Author Correction: Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.
Masud SN; Chandrashekhar M; Aregger M; Tan G; Zhang X; Mero P; Pirman DA; Zaslaver O; Smolen GA; Lin ZY; Wong CJ; Boone C; Gingras AC; Montenegro-Burke JR; Moffat J
Nat Chem Biol; 2022 Oct; 18(10):1162. PubMed ID: 36002506
[No Abstract] [Full Text] [Related]
7. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
Zheng L; Liu Y; Pan J
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
[TBL] [Abstract][Full Text] [Related]
8. Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.
Barbarino M; Cesari D; Intruglio R; Indovina P; Namagerdi A; Bertolino FM; Bottaro M; Rahmani D; Bellan C; Giordano A
J Cell Physiol; 2018 Sep; 233(9):7391-7401. PubMed ID: 29659015
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.
Thorne CA; Hanson AJ; Schneider J; Tahinci E; Orton D; Cselenyi CS; Jernigan KK; Meyers KC; Hang BI; Waterson AG; Kim K; Melancon B; Ghidu VP; Sulikowski GA; LaFleur B; Salic A; Lee LA; Miller DM; Lee E
Nat Chem Biol; 2010 Nov; 6(11):829-36. PubMed ID: 20890287
[TBL] [Abstract][Full Text] [Related]
10. Pyrvinium pamoate can overcome artemisinin's resistance in anaplastic thyroid cancer.
Li Y
BMC Complement Med Ther; 2021 May; 21(1):156. PubMed ID: 34049534
[TBL] [Abstract][Full Text] [Related]
11. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
Xu W; Lacerda L; Debeb BG; Atkinson RL; Solley TN; Li L; Orton D; McMurray JS; Hang BI; Lee E; Klopp AH; Ueno NT; Reuben JM; Krishnamurthy S; Woodward WA
PLoS One; 2013; 8(8):e71508. PubMed ID: 24013655
[TBL] [Abstract][Full Text] [Related]
12. Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy.
Yu DH; Macdonald J; Liu G; Lee AS; Ly M; Davis T; Ke N; Zhou D; Wong-Staal F; Li QX
PLoS One; 2008; 3(12):e3951. PubMed ID: 19079611
[TBL] [Abstract][Full Text] [Related]
13. Pyrvinium targets autophagy addiction to promote cancer cell death.
Deng L; Lei Y; Liu R; Li J; Yuan K; Li Y; Chen Y; Liu Y; Lu Y; Edwards CK; Huang C; Wei Y
Cell Death Dis; 2013 May; 4(5):e614. PubMed ID: 23640456
[TBL] [Abstract][Full Text] [Related]
14. The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (
Shen C; Li B; Astudillo L; Deutscher MP; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
Biochemistry; 2019 Dec; 58(51):5102-5106. PubMed ID: 31820934
[TBL] [Abstract][Full Text] [Related]
15. Pyrvinium doubles against WNT-driven cancer.
Fan J; Reid RR; He TC
J Biol Chem; 2022 Oct; 298(10):102479. PubMed ID: 36096200
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
17. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
18. Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.
Hatamipour M; Jaafari MR; Zangui M; Shakour N; Sahebkar A
Anticancer Agents Med Chem; 2021; 21(17):2379-2384. PubMed ID: 33596812
[TBL] [Abstract][Full Text] [Related]
19. Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells.
Karamian A; Nazarian H; Ziai SA; Zarnani AH; Salehpour S; Paktinat S; Novin MG
Hum Exp Toxicol; 2020 May; 39(5):662-672. PubMed ID: 31880170
[TBL] [Abstract][Full Text] [Related]
20. Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug.
Schultz CW; Nevler A
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
